Table 1.
Baseline socio-demographic and clinical characteristics of the study participants
| Variables | Sex | Age Category | Total | |||
|---|---|---|---|---|---|---|
| Male | Female | Under 5 | 5 to 15 | > 15 | ||
| Participants, n | 66 | 34 | 17 | 53 | 30 | 100 |
| Previous malaria, n (%) | 60 (69%) | 27 (31%) | 11 (12.6%) | 49 (56.4%) | 27 (31%) | 87 (87%) |
| Previous CQ intake, n (%) | 22 (61%) | 14 (39%) | 6 (17%) | 22 (61%) | 8 (22%) | 36 (41%) |
| Temp (0C), mean ± SD | 38.1 (0.77) | 38.0 (0.6) | 38.4 (0.8) | 38.1 (0.6) | 37.9 (0.69) | 38.1 (0.72) |
| Temp ≥ 37.50C, n (%) | 59 (66%) | 31(34%) | 16 (18%) | 50 (55%) | 24 (27%) | 90 (90%) |
| Geometric mean para/μL (Min–Max) para/μL | 5529 (872–36,040) | 5203 (504–32,000) | 9990 (1670–36,040) | 6671 (504–28,800) | 2648 (800–15,000) | 5416 (504–36,040) |
| Gametocyte carriage, n (%) | 32 (76%) | 10 (24%) | 9 (21%) | 21 (50%) | 12 (29%) | 42 (42%) |
| Hb (g/dL), mean ± SD | 12.2 (1.17) | 11.6 (1.66) | 11.6 (1.46) | 11.8 (1.33) | 12.5 (1.33) | 12 (1.38) |
| Anemia status, n (%) | 14 (54%) | 12 (46%) | 5 (19%) | 13 (50%) | 8 (31%) | 26 (26%) |
CQ Chloroquine, °C Degree Celsius, g/dL gram per deciliter, Hgb Hemoglobin, μL Microliter, n number, SD Standard Deviation